Regencell Bioscience
5 hedge funds and large institutions have $434K invested in Regencell Bioscience in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+3
Holders Change %
+150%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$371K |
| 2 |
2
Citigroup
New York
|
$48K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$10K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$5K |
Top Sellers
| 1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Qube Research & Technologies (QRT)
London,
United Kingdom
| $371K | +$371K | +658,502 | New |
|
|
2
Citigroup
New York
| $48K | +$48K | +85,120 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $10K | +$10K | +16,416 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $5K | +$1.07K | +1,976 | +27% |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| – | -$224K | -259,008 | Closed |
|